Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

DYRK1a Inhibitor Mediated Rescue of Drosophila Models of Alzheimer’s Disease-Down Syndrome Phenotypes
Bangfu Zhu, Tom Parsons, Wenche Stensen, et al.
Frontiers in Pharmacology (2022) Vol. 13
Open Access | Times Cited: 11

Showing 11 citing articles:

Type 2 Diabetes Mellitus and Alzheimer’s Disease: Shared Molecular Mechanisms and Potential Common Therapeutic Targets
Rim Hamzé, Etienne Delangre, Stefania Tolu, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 23, pp. 15287-15287
Open Access | Times Cited: 94
Comparative Efficacy and Selectivity of Pharmacological Inhibitors of DYRK and CLK Protein Kinases
Mattias F. Lindberg, Emmanuel Deau, Jonas Arfwedson, et al.
Journal of Medicinal Chemistry (2023) Vol. 66, Iss. 6, pp. 4106-4130
Closed Access | Times Cited: 25
Genetic forms of tauopathies: inherited causes and implications of Alzheimer’s disease-like TAU pathology in primary and secondary tauopathies
Felix Langerscheidt, Tamara Wied, Mohamed Aghyad Al Kabbani, et al.
Journal of Neurology (2024) Vol. 271, Iss. 6, pp. 2992-3018
Open Access | Times Cited: 13
Leucettinibs, a Class of DYRK/CLK Kinase Inhibitors Inspired by the Marine Sponge Natural Product Leucettamine B
Emmanuel Deau, Mattias F. Lindberg, Frédéric Miege, et al.
Journal of Medicinal Chemistry (2023) Vol. 66, Iss. 15, pp. 10694-10714
Closed Access | Times Cited: 14
Using Drosophila to Study the Mechanisms That Underlie Down Syndrome
Bing Ye
(2025), pp. 151-186
Closed Access
Leucettinib-21, a DYRK1A Kinase Inhibitor as Clinical Drug Candidate for Alzheimer’s Disease and Down Syndrome
Laurent Meijer, Emilie Chrétien, Denis Ravel
Journal of Alzheimer s Disease (2024) Vol. 101, Iss. s1, pp. S95-S113
Closed Access | Times Cited: 3
Modeling neurodegenerative and neurodevelopmental disorders in theDrosophilamushroom body
Aaron Stahl, Seth M. Tomchik
Learning & Memory (2024) Vol. 31, Iss. 5, pp. a053816-a053816
Open Access | Times Cited: 2
Drosophila as a Model for Human Disease: Insights into Rare and Ultra-Rare Diseases
Sergio Casas‐Tintó
Insects (2024) Vol. 15, Iss. 11, pp. 870-870
Open Access | Times Cited: 2
Insights from the protein interaction Universe of the multifunctional “Goldilocks” kinase DYRK1A
Varsha Ananthapadmanabhan, Kathryn H. Shows, Amanda Dickinson, et al.
Frontiers in Cell and Developmental Biology (2023) Vol. 11
Open Access | Times Cited: 5
Psychoplastogenic DYRK1A Inhibitors with Therapeutic Effects Relevant to Alzheimer’s Disease
Hunter T. Warren, Hannah N. Saeger, Robert J. Tombari, et al.
Journal of Medicinal Chemistry (2024) Vol. 67, Iss. 9, pp. 6922-6937
Closed Access | Times Cited: 1
The Power of the Rocking Cradle: Improving Sleep Function by Gentle Vibration
Makenzie A. Hopkins, Masashi Tabuchi
SLEEP (2024)
Open Access
Page 1

Scroll to top